Therefore, the present study not only contributes to the understanding of the physiopathogenic mechanisms underlying T. cruzi infection but also indicate the influence of the concentration of T. cruzi during infection and the immunosuppression through the iNOS pathway in clinical laboratory heterogeneity reported in acute Chagas disease. The gene discussed is NOS2; the disease is Chagas disease.